Gossamer Bio
Latest round
- Series B
Last raised
- Jul 2018
Total raised
- $330M
Investors
- 7
About Gossamer Bio
Gossamer Bio, Inc.Gossamer Bio, Inc. was founded in 2017 and is headquartered in San Diego, US. The company focuses on developing treatments for pulmonary diseases and has engaged in four significant deals as part of its operational strategy. The founder and CEO, Faheem Hasnain, has a history of leading biopharmaceutical companies.Gossamer Bio primarily focuses on the development of seralutinib, an investigational inhaled drug designed to treat pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). This inhaled product operates as a PDGFRa/ß, CSF1R, and c-KIT inhibitor and is administered via a dry powder inhaler. The PROSERA Study, currently in phase 3 clinical trials, evaluates the efficacy and safety of seralutinib in adults with PAH, emphasizing the unmet medical needs in this patient population.70 mn in the most recent year, 2024.92 mn for the same period. The company targets expansion into new healthcare markets in Europe and the US by the end of 2024, with a focus on enhancing access to its therapies.
Who invested in Gossamer Bio
7 investors across 3 rounds
See all investors in Gossamer Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gossamer Bio
Who invested in Gossamer Bio?
Gossamer Bio has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gossamer Bio raised?
Gossamer Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Gossamer Bio last raise money?
Gossamer Bio's most recent round on record is a Series B, in Jul 2018.
What does Gossamer Bio do?
Gossamer Bio is a pharmaceuticals company.
Where is Gossamer Bio headquartered?
Gossamer Bio is headquartered in San Diego, US.
Which VCs invest in companies like Gossamer Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Gossamer Bio's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Gossamer Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.